Tel-aviv Sourasky Medical Center

This study is testing a new under-the-skin injection called mosunetuzumab for people with a slow-growing type of blood cancer called follicular lymphoma who haven't had any treatment yet. The goal is to see if this immunotherapy can effectively shrink tumors while being more conv…

This early-stage study is testing the safety of adding an experimental drug called CLS-015 to standard CAR-T cell therapy for adults with large B-cell lymphoma. It focuses on patients whose cancer is stable or growing just before their CAR-T treatment, a group with a high risk of…